Kicking ADCs up a notch
Orchid at Vizcaya Museum in Miami – always thought they looked like chemical structures showing us the gaps!
We highlighted a number of different types of antibody drug conjugates (ADCs) recently – yes, there’s much more to this category than simply dropping a chemo cargo on cancer cells!
In this review, we explore one of those flexible functionalities in more depth.
The cool thing about having an antibody base is creative chemists can bolt different things onto them, depending on what their goal is.
There are some really cool technology ideas being explored in research right now, which may improve not only what we can do with ADCs but also another modality.
If we think of the ADC as a modern day Trojan Horse to hide or mask the real payload in some way, the possibilities become limited only by our imagination.
The good news is there’s more than one example of this new genre to explore…
To continue reading our latest highlights on oncology new product development including commentary and analysis BSB subscribers can log-in or you can click to access the content.
This content is restricted to subscribers
